Eva Arlander

Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors*

Eva Arlander, Gunilla Ekström, Christina Alm et al. · Clinical Pharmacology & Therapeutics · 1998 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +17

Ropivacaine gel in active distal ulcerative colitis and proctitis—a pharmacokinetic and exploratory clinical study

Eva Arlander, Åke Öst, D. STÅHLBERGS et al. · Alimentary Pharmacology & Therapeutics · 1996 · 66 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +17

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Sara Montagnese, Mette Munk Lauridsen, Hendrik Vilstrup et al. · Journal of Hepatology · 2021 · 58 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebo-controlled, patient-initiated clinical trial

Christopher Hull, Johan Harmenberg, Eva Arlander et al. · Journal of the American Academy of Dermatology · 2010 · 30 citations

Medicine, Dermatology, Pharmacotherapy +11

Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine

Alan N. Sandler, Eva Arlander, Brendan T. Finucane et al. · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 1998 · 20 citations · Full text

Veterinary Medicine, Anesthesiology, Pharmacokinetics +12